Change Theme
Business Standard
Sat, Aug 24, 2024
DRL's Andhra Pradesh facility gets 3 observations from USFDA
Dr Reddy's Laboratories said that the US drug regulator has issued Form 483, with three observations after inspecting its Andhra Pradesh manufacturing facility.